To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
.
News
Vesalius News
10/20/2025
CatalYm: Long-Term Phase 1/2a Data
read more
10/17/2025
CatalYm: Phase 2 Data Bladder Cancer
read more
09/30/2025
CatalYm: First Patient Dosed NSCLC
read more
.
xxnoxx_zaehler